SMTL ID : 2ze2.1

Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (RT) in complex with TMC278 (rilpivirine), a non-nucleoside RT inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-1-mer

Ligands

1 x T27: 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile(Non-covalent)

T27.1: 15 residues within 4Å: Chain A: P.97, I.102, K.103, N.105, V.181, Y.183, Y.190, P.227, F.229, L.230, W.231, L.236, H.237, P.238, Y.320 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:P.97, A:N.105, A:V.181, A:V.181, A:Y.183, A:Y.183, A:Y.183, A:Y.190, A:W.231, A:W.231 Hydrogen bonds: A:K.103, A:K.103, A:Y.190

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Das, K. et al., High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations. Proc.Natl.Acad.Sci.Usa (2008)

Release Date

2008-02-12

Peptides

Reverse transcriptase/ribonuclease H: A
p51 RT: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Reverse transcriptase/ribonuclease H

p51 RT

Related Entries With Identical Sequence